AIM ImmunoTech Book Value Per Share vs. Earnings Per Share
| 0A4Y Stock | 0.23 0.01 4.55% |
For AIM ImmunoTech profitability analysis, we use financial ratios and fundamental drivers that measure the ability of AIM ImmunoTech to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well AIM ImmunoTech utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between AIM ImmunoTech's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of AIM ImmunoTech over time as well as its relative position and ranking within its peers.
AIM |
AIM ImmunoTech Earnings Per Share vs. Book Value Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining AIM ImmunoTech's current stock value. Our valuation model uses many indicators to compare AIM ImmunoTech value to that of its competitors to determine the firm's financial worth. AIM ImmunoTech is number one stock in book value per share category among its peers. It also is number one stock in earnings per share category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AIM ImmunoTech's earnings, one of the primary drivers of an investment's value.AIM Earnings Per Share vs. Book Value Per Share
Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
AIM ImmunoTech |
| = | 0.19 X |
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
AIM ImmunoTech |
| = | (0.40) X |
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
AIM Earnings Per Share Comparison
AIM ImmunoTech is currently under evaluation in earnings per share category among its peers.
AIM ImmunoTech Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in AIM ImmunoTech, profitability is also one of the essential criteria for including it into their portfolios because, without profit, AIM ImmunoTech will eventually generate negative long term returns. The profitability progress is the general direction of AIM ImmunoTech's change in net profit over the period of time. It can combine multiple indicators of AIM ImmunoTech, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Interest Income | 521 K | 422.2 K | |
| Operating Income | -13.5 M | -14.2 M | |
| Income Before Tax | -13 M | -13.6 M | |
| Net Loss | -17.2 M | -18.1 M | |
| Net Loss | -17.5 M | -18.4 M | |
| Change To Netincome | 4 M | 4.2 M |
AIM Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on AIM ImmunoTech. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of AIM ImmunoTech position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the AIM ImmunoTech's important profitability drivers and their relationship over time.
Use AIM ImmunoTech in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AIM ImmunoTech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AIM ImmunoTech will appreciate offsetting losses from the drop in the long position's value.AIM ImmunoTech Pair Trading
AIM ImmunoTech Pair Trading Analysis
The ability to find closely correlated positions to AIM ImmunoTech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AIM ImmunoTech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AIM ImmunoTech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AIM ImmunoTech to buy it.
The correlation of AIM ImmunoTech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AIM ImmunoTech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AIM ImmunoTech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AIM ImmunoTech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your AIM ImmunoTech position
In addition to having AIM ImmunoTech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Financials Thematic Idea Now
Financials
Companies that provide financial services to business or retail customers. The Financials theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for AIM Stock Analysis
When running AIM ImmunoTech's price analysis, check to measure AIM ImmunoTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AIM ImmunoTech is operating at the current time. Most of AIM ImmunoTech's value examination focuses on studying past and present price action to predict the probability of AIM ImmunoTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AIM ImmunoTech's price. Additionally, you may evaluate how the addition of AIM ImmunoTech to your portfolios can decrease your overall portfolio volatility.